Ehlers-Danlos Syndrome with Glycosaminoglycan Abnormalities: A Report of the Rare Musculocontractural and Spondylodysplastic Subtypes
Roopadarshini B1, Neelam Saini1, Ashwin Dalal2, Shagun Aggarwal1,2 1 Department of Medical Genetics, Nizam’s Institute of Medical Sciences, Hyderabad, Telangana, India. 2 Diagnostics Division, Centre for DNA Fingerprinting and Diagnostics, Hyderabad, Telangana, India. Correspondence to: Dr. Shagun AggarwalEmail:shagun.genetics@gmail.com
1 Abstract
Ehlers-Danlos syndrome (EDS) is a heterogeneous group of genetic connective tissue disorders characterized by skin
hyperextensibility, joint hypermobility, and atrophic scarring. The majority of cases are caused by mutations in the
collagen-encoding or collagen-modifying genes. A rarer subset of EDS with atypical presentation is caused by an
abnormality in glycosaminoglycan synthesis- the spondylodysplastic type of EDS related to mutations in the genes
B4GALT7, B3GALT6 or SLC39A13, and the musculocontractural EDS caused by biallelic pathogenic variants in
CHST14 or DSE genes. We report two cases of EDS related to CHST14 and B3GALT6 gene variants and discuss the
unique features of these rarer subtypes.
Ehlers-Danlos syndrome (EDS) is a heterogeneous group of genetic connective tissue disorders characterized by skin
hyperextensibility, joint hypermobility, and atrophic scarring caused primarily by mutations in the collagen-encoding
genes or genes encoding collagen-modifying enzymes. The 2017 International Classification of the Ehlers–Danlos
Syndromes describes 13 types based on characteristic phenotypic manifestations (Malfait et al., 2017). The tenth
subtype of EDS as per this nosology is caused by variations in genes coding for the enzymes responsible
for adding sugar moieties to the linker region of proteoglycans and are also classified as “linkeropathies”
(Caraffi et al., 2019). This subtype of EDS is called the spondylodysplastic EDS, previously classified as the
progeroid EDS. Mutations in the genes B4GALT7 and B3GALT6 (coding for galactosyltransferase I and II
respectively) and SLC39A13 are described to be causative. Specific clinical diagnostic criteria have been
defined, of which the major criteria comprise progressive short stature, hypotonia, and bowing of limbs. The
eleventh described subtype called the musculocontractural Ehlers–Danlos Syndrome (MC-EDS) is caused by
biallelic pathogenic variants in the gene for carbohydrate sulfotransferase 14/ dermatan 4-O-sulfotransferase 1
(CHST14/D4ST1) (MIM#601776), or the gene for dermatan sulfate epimerase (DSE) (MIM#615539) (Kosho et
al., 2016; Brady et al., 2017). Major criteria for this subtype are multiple congenital joint contractures,
characteristic facies, and prominent skin findings. Both the above types of EDS have common molecular
abnormalities involving glycosaminoglycans which play an important role in the formation of collagen fibrils in the
connective tissue. We describe one case each of musculocontractural EDS type 1 (CHST14 associated) and
spondylodysplastic EDS type 2 (B3GALT6 associated), further reiterating the phenotypic spectrum of these
conditions.
Figure 1: Child with EDS musculocontractural type 1. (A) Hypertelorism, epicanthal folds, down slanting palpable
fissures, sagging skin on cheeks. (B) Excessive wrinkling & sagging of skin over the chest and abdomen with pectus
excavatum. (C) Progeroid appearance, bilateral club feet, increased gap between 1st and 2nd toes, spatulate toes,
callosity with scarring on the anterior aspect of the knee (D) Brachycephalic skull, low-set ears (E) Blue sclerae
3 Patient description:
Patient 1: A 2-year-8-month-old female child, fifth born to third-degree consanguineous parents, was brought to the
genetics clinic with bilateral clubfoot deformity since birth and motor developmental delay. She was born at term with a
birth weight of 3.5 kg. A significant motor delay was evident, and she had not achieved independent ambulation.
Craniofacial dysmorphism was appreciated in the form of a brachycephalic skull, tall forehead, hypertelorism, down
slanting palpebral fissure, epicanthal folds, blue sclera, broad nasal bridge, and long, smooth philtrum (Figures 1A, 1D& 1E). On head-to-toe examination, widely spaced nipples with sagging skin, increased skin fold over the trunk and
abdomen, pectus excavatum (Figure 1B), and bilateral talipes equinovarus deformity were seen (Figure 1C). The skin
had a soft doughy feel, was hyperextensible, and had excessive wrinkles. Shallow palmar creases were seen. Significant
joint laxity and hypotonia were appreciated. The Z-scores for head circumference (-3.32), weight (-4.15),
and height (-3.31) indicated significant failure to thrive. Other systemic examinations were normal. Her
intellect and vision were normal. A provisional clinical diagnosis of cutis laxa or Ehlers-Danlos syndrome was
made.
Figure 2: Child with EDS spondylodysplastic type 2. (A) Frontal bossing, deep-set eyes, long prominent philtrum,
low-set prominent ears, sparse scalp hair. (B) Prominent eyes with mild down slant, and sagging cheeks. (C)
Increased skin folds over the chest and abdomen. (D) & (E) Spatulate toes with radial deviation, long tapering
fingers with ulnar deviation of third to fifth digit, and flexion contractures of proximal interphalangeal joints. (F)
& (G) X-ray chest and spine showing exaggerated thoracic kyphosis with lumbar lordosis, unremarkable ribs, and
vertebral bodies (H) X-ray pelvis showing bilateral hip dislocation.
A skeletal survey showed scoliosis of the thoracolumbar spine and developmental dysplasia of bilateral hips. Hearing
evaluation revealed bilateral profound hearing loss. Magnetic resonance imaging (MRI) of the brain showed T1
hypointensity and T2 hyperintensities in the subcortical region, involving the corpus callosum and corona radiata of the
bilateral frontal regions (Figure 3A). 2D echocardiography of the heart and ophthalmological evaluation were within
normal limits. Whole exome sequencing from peripheral leucocyte DNA revealed a homozygous missense variant in the
CHST14 gene (NM_130468.4) c.652C>A; p.Arg218Ser. Computational analysis with online tools such as Frankin by
Genoox (https://franklin.genoox.com/analysis-tool/join-cta) and VarSome (https://varsome.com/)
showed it was a likely pathogenic variant [criteria PP3 + PM2 + PP5 as per variant classification guidelines of the
American College of Medical Genetics and Genomics & Association for Molecular Pathology (ACMG/AMP)] and was
consistent with the clinical phenotype. The patient was diagnosed to be affected with Ehlers-Danlos syndrome, MC-EDS
type 1.
Figure 3: MRI images showing white matter changes in the child with MC-EDS [A] T2 hyperintensities in
subcortical regions of bilateral frontal lobes [B] T2 hyperintensities in bilateral centrum semiovale.
Patient 2: An 8-month-old boy, second born to a non-consanguineous couple, was brought with a history of motor
developmental delay and developmental dysplasia of the hip (DDH). He was born at term with a weight
of 3.5 kg. A plaster cast was applied for DDH at 4 months of age. On examination, he had craniofacial
dysmorphisms such as frontal prominence, plagiocephaly, midface hypoplasia, deep-set prominent eyes with
mild down slant, and long philtrum (Figure 2A & 2B). Sparse scalp hair (Figure 2A), and increased
skin folds over the chest and abdomen were observed (Figure 2C). Increased joint laxity especially of
hand and feet with a Beighton score of 6/9, and soft skin with increased palmar creases was appreciated.
Spatulate toes with radial deviation, broad first toe, long tapering fingers with ulnar deviation of third to fifth
digits, and flexion contractures of proximal interphalangeal joints were noted (Figures 2D & 2E). Hearing,
vision, and cognition were normal. Length (67 cm) was on the 5th centile, head circumference (44 cm)
on the 33rd centile, and weight (7 kg) on the 3rd centile. Central nervous system examination revealed
hypotonia with diminished deep tendon reflexes. The pelvic radiograph showed bilateral hip dislocation (Figure2H).
2D echocardiography detected a 3mm patent foramen ovale. Mixed hearing loss (unilateral) was present, and eye
evaluation was normal. Radiographs showed generalized osteopenia with thin cortices, wavy long bones and ribs, thoracic
kyphosis, and exaggerated lumbar lordosis (Figures F&G). A provisional diagnosis of Ehlers-Danlos syndrome or Larsen
syndrome was made. Whole exome sequencing from leukocyte DNA revealed two variants in the B3GALT6 gene,
(NM_080605.4) c.545A>G; p.Tyr182Lys, a previously reported likely pathogenic variant (criteria PP3 + PM2 + PP2 +
PP5 as per ACMG/ AMP guidelines) (Van Damme et al., 2018); and c.749C>T; p. Ala250Val, a novel variant of
uncertain significance (criteria PM2 + PM1 + PP2 + PP3 as ACMG/ AMP guidelines). Both variants are not present in
publicly available population databases (dbSNP - http://www.ncbi.nlm.nih.gov/SNP; 1000 Genomes -
https://www.internationalgenome.org/; gnomAD - https://gnomad.broadinstitute.org/) in-silico prediction
programs like SIFT (https://sift.bii.a-star.edu.sg/); PolyPhen-2 (http://genetics.bwh.harvard.edu/pph2/);
MutationTaster2 (https://www.mutationtaster.org/); and CADD (https://cadd.bihealth.org/)
predicted both these variants to be deleterious. Parental segregation analysis revealed each of the variants
to be present in a heterozygous state in one of the parents. The clinical presentation and the molecular
report indicated that the patient was affected with Spondylodysplastic Ehlers-Danlos syndrome type 2
(EDSSPD2).
4 Discussion
MC-EDS was reported to be caused by biallelic variants in the CHST14 gene by Dundar et al. (2009). At present, 66
patients with 48 families are reported in the literature (Minatogawa et al., 2022). Syx et al. (2015), described two patients
from the same family, with homozygous c.652C>A variants in the CHST14 gene, similar to our case. These patients
presented with severe bilateral talipes equinovarus, dislocation of the hip but no adducted thumbs. Speech and motor
development were delayed, in contrast to our case report where only motor developmental delay was evident. Very few
Indian cases are reported (Lautrup et al., 2020). The clinical phenotype of our patient is consistent with
the known phenotypic spectrum of this condition. However, our patient does not report any significant
morbidity in the form of subcutaneous hematomas, recurrent joint dislocations, or systemic complications. This
indicates possibly a mild phenotypic presentation or these findings could evolve. An unusual finding was
the white matter changes in brain imaging. Previous reports have described periventricular heterotopias,
ventricular enlargement/ asymmetry, absence of the left septum pellucidum, short corpus callosum, and
cerebellar hypoplasia (Minatogawa et al., 2022). Mice models by Li et al. (2019) showed that Chst14/D4st1
deficiency resulted in impaired spatial learning, memory, and long-term potentiation. Chondroitin and dermatan
sulfate are extracellular components of the central nervous system (CNS) and interact with growth factors
and neurotrophic factors influencing neuronal migration, axon guidance, neurite outgrowth, and synaptic
plasticity. The CNS findings in our case were likely a part of the EDS phenotype, and follow-up has been
advised.
Mutations in B3GALT6 were first described by Nakajima et al. (2013). Subsequently, Damme et al. (2018), described
12 cases of biallelic B3GALT6 gene mutations causing EDSSPD. In recent literature, a heterozygous variant in B3GALT6
co-segregated with clinical features such as elbow contracture, scoliosis, and facial dysmorphism (Shen et al., 2022). All
patients with homozygous variants had features of both EDS and spondylo-meta-epiphyseal dysplasia. Some of them
had complications like aortic dilatation/ aneurysm, cervical spine instability, and respiratory insufficiency.
B3GALT6 mutation causes complete loss of galactosyltransferase activity leading to deficient GAG synthesis
and disrupted collagen organization. A patient with the variant (c.545A>G) in a homozygous state was
described in a 3-year-old Iranian boy born of a consanguineous couple. Facial features were similar in both
cases like frontal bossing, midface hypoplasia, downward slanting eyes, and long prominent philtrum. As of
today, disease-causing variations in the B3GALT6 gene have been reported in around 50 patients. The
facial dysmorphic features, skin findings, and joint abnormalities in the previously reported patients are
similar to the findings in our case. Previous studies have shown a significant burden of skeletal abnormalities
including spinal deformities, fractures, and short stature, which were not present in our patient. These
may be age-dependent features. Regular follow-up and serial radiographs are planned for the patient to
look for these evolving findings. Tables 1 & 2 depict the diagnostic major and minor criteria for these
rare subtypes of EDS as per the nosology along with the features as seen in these two cases. Although
hearing loss is not included in the major or minor criteria, both of our patients presented with sensorineural
hearing loss, and similar cases have been reported in literature associated with both these subtypes of
EDS.
These two patients reiterate the phenotypic presentation of two relatively rarer subtypes of EDS syndrome which
involve abnormalities of the glycosaminoglycans (GAGs). GAGs are important components of connective tissue and help
in the formation of the collagen fibril network. Disorders of their synthesis and processing result in complex forms of EDS
which present with a more complicated clinical phenotype as compared to the EDS resulting from collagen mutations.
This phenotype includes significant skeletal abnormality as seen in B3GALT6-associated EDSSPD, joint contractures as
seen in CHST14-associated MC-EDS, as well as more widespread systemic involvement in the form of structural cardiac
defects, brain abnormalities, ophthalmic, and hearing abnormalities, etc. This indicates the ubiquitous role of GAGs
during embryonic development as well as a role in connective tissue integrity throughout the lifespan of the
individual.
Plagiocephaly, prominent
forehead 90%
Asymmetric face & flat midface
75%
Straight and fine hair 45%
Sparse eyelashes
Blue sclerae 70%
Proptosis 60%
Down-slanting palpebral fissures,
High and narrow palate,
malocclusion,
low-set ears
+
+
+
+
+
+
7. Tooth discoloration, dysplastic teeth
75%
CHARACTERISTICRADIOGRAPHICFINDINGS
1. Osteoporosis with multiple
spontaneous fractures
2. Ascending aorta aneurysm
3. Lung hypoplasia, restrictive lung
disease
CLINICAL DIAGNOSIS
1 and 2 of the major criteria plus
characteristic radiographic
abnormalities and at least 3 minor
criteria
2 major
and 7
minor
criteria
5 Conclusion
EDS resulting from glycosaminoglycan abnormalities are rarer, show severe phenotypes with multi-systemic involvement,
and overlap with other conditions like skeletal dysplasia and arthrogryposis. Deep phenotyping helps in the computational
analysis of exome sequencing data sets, enabling timely and accurate molecular diagnosis. This is crucial for adequate
managem-
ent, follow-up, and prevention of complications, to predict recurrence risk in the family, and for timely prenatal invasive
testing. Quality of life can be improved with proper rehabilitation. Diligent follow-up of cases helps in preventing
life-threatening complications or early death/ disability due to ruptured or dissecting aneurysm, massive hematomas, poor
wound healing/infection, retinal detachment, fractures, joint dislocation followed by vascular or neural
compromise.
Conflict of Interests: None
Declaration: Informed consent was taken for clinical photographs from the guardian.
Acknowledgments: The authors thank the family for their participation in the study and also Medgenome Labs and
the Centre for Cellular and Molecular Biology (CCMB).
References
1. Brady AF, et al. The Ehlers-Danlos syndromes, rare types. Am J Med Genet C Semin Med Genet.
2017;175(1):70-115.
2. Caraffi SG, et al. Severe Peripheral Joint
Laxity is a Distinctive Clinical Feature of Spondylodysplastic-Ehlers-Danlos Syndrome (EDS)-B4GALT7 and
Spondylodysplastic-EDS-B3GALT6. Genes (Basel). 2019;10(10):799.
3. Dundar M, et al. Loss of dermatan-4-sulfotransferase 1 function results in adducted thumb-clubfoot
syndrome. Am J Hum Genet. 2009;85(6):873-82.
4. Kosho T, et al. CHST14/D4ST1 deficiency: a new form of Ehlers-Danlos syndrome. Pediatr Int.
2016;58(2):88-99.
5. Kosho T, et al. Recent Advances in the Pathophysiology of Musculocontractural Ehlers-Danlos Syndrome.
Genes (Basel). 2019;11(1):43.
6. Lautrup CK, et al. Delineation of Musculocontractural Ehlers-Danlos Syndrome caused by dermatan
sulfate epimerase deficiency. Mol Genet Genomic Med. 2020;8(5): e1197.
7. Malfait F, et al. The 2017 international classification of the Ehlers-Danlos syndromes. Am J Med Genet
C Semin Med Genet. 2017;175(1):8-26.
8. Minatogawa M, et al. Clinical and molecular features of 66 patients with Musculocontractural
Ehlers-Danlos syndrome caused by pathogenic variants in CHST14 (mcEDS-CHST14). J Med Genet.
2022;59(9):865-877.
9. Nakajima M, et al. Mutations in B3GALT6, which encodes a glycosaminoglycan linker region enzyme,
cause a spectrum of skeletal and connective tissue disorders. Am J Hum Genet. 2013;92(6):927-34.
10. Syx D, et al. Genetic heterogeneity and clinical variability in musculocontractural Ehlers-Danlos syndrome
caused by impaired dermatan sulfate biosynthesis. Hum Mutat. 2015;36(5):535-47.
11. Van Damme T, et al. Biallelic B3GALT6 mutations cause spondylodysplastic Ehlers-Danlos syndrome.
Hum Mol Genet. 2018;27(20):3475-3487.
12. Li Q, et al. Impaired cognitive function and altered hippocampal synaptic plasticity in mice lacking
dermatan sulfotransferase Chst14/D4st1. Front Mol Neurosci. 2019; 12: 26.
13. Shen F, et al. Mutant B3GALT6 in a Multiplex family: a dominant variant co-segregated with moderate
malformations. Front Genet. 2022; 13:824445.